StockNews.AI
EVO
StockNews.AI
29 days

Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance

1. Evotec updates 2025 revenue guidance to €760-800m, down from €840-880m. 2. R&D expenses and adjusted EBITDA guidance remain unchanged for financial stability. 3. Revenue drop attributed to a change in revenue mix and market challenges. 4. Technology licensing expected to contribute significantly to future revenues. 5. Actions are underway for sustainable growth despite current revenue underperformance.

Earnings
-13.38%Current Return
VS
+0.19%S&P 500
$4.2607/21 06:00 AM EDTEvent Start
$3.6907/22 09:04 AM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Bearish?

The reduction in revenue guidance indicates weaker-than-expected performance and outlook. Historically, similar downward revisions led stocks to decline temporarily.

How important is it?

The updated guidance is critical for investor expectations and future performance metrics. A significant change in revenue guidance typically influences stock prices significantly.

Why Short Term?

Immediate reactions will stem from revenue guidance revisions, affecting short-term investor sentiment. Long-term outlook could improve with successful technology licensing.

Related Companies

EVT
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces that it has updated its revenue guidance for the fiscal year 2025. Guidance on R&D expenses and adjusted EBITDA remains unchanged.For the current fiscal year, the Company expects Group revenues in the range of€760-800m (previously: € 840 - 880 m; 2024: € 797.0 m);R&D expenditures are expected in a range of €40 - 50 m (unchanged; 2024: € 50.8 m);Adjusted EBITDA is expected to reach €30-50m (unchanged; 2024: € 22.6 m).The primary reasons for the refined guidance are a change in the revenue mix and significant cost savings in excess of initial targets set during the Priority Reset. Technology licensing - a key pillar of Evotec's strategic repositioning - is expected to make a stronger contribution. At the same time, the Shared R&D base business is expected to continue to operate in a challenging market environment in the second half of 2025. Group revenues were below expectations in H1 2025, while adjusted EBITDA was broadly in line with expectations. Actions are underway to transform the business towards sustainable profitable growth.- End of the ad hoc release -Contact: Volker Braun, EVP Head of Global Investor Relations & ESG, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49(0)151 1940 5058 (m), [email protected] SOURCE: Evotec SE

Related News